Amazon’s PillPack deal puts PBMs, advisers on notice
With employers and employees going directly to the source for their specialty drug needs, pharmacy benefit managers and brokers will need to adapt quickly to a new healthcare landscape.
Pharmacy benefit management
Is the Amazon deal a bitter pill for healthcare? Experts weigh in
The online retail conglomerate takes another step into the health market with its announcement to buy PillPack, surprising several industry leaders.
Is the Amazon deal a bitter pill for brokers? Healthcare experts weigh in
The online retail conglomerate takes another step into the healthcare market with its announcement to buy online pharmacy, surprising several industry leaders.
NAHU debate: The high cost of medication in America
With the updates to Medicare after the passing of the Affordable Care Act prescription drug cost is running rampant due to the inability to negotiate price and the lack of benchmarks for stability.
Benefits Think ‘Right to try’ is compassionate legislation, but does it make sense?
A “Hail Mary” pass is understandable when it comes to treating a seriously ill loved one, but questions remain about reimbursement.
Craig Hasday
Frenkel Benefits
Amazon makes big foray into healthcare with PillPack purchase
The transaction sets up a showdown between Amazon and pharmacy benefit managers including Express Scripts, which recently agreed to be acquired by health insurer Cigna and CVS Health.
NAHU debate: The high cost of medication in America
With the updates to Medicare after the passing of the Affordable Care Act prescription drug cost is running rampant due to the inability to negotiate price and the lack of benchmarks for stability.
A cure for high pharma costs? Import drugs, export patients
Attempting to circumvent the costly specialty drug chain, brokers are encouraging clients to shop for FDA-approved drugs outside the U.S.
BeneCard’s value-based care model to opioid scripts cuts doses to five days
By continually reviewing prescription benefit policies and adapting them to current clinical information, employees are limited to their first exposure to addictive painkillers.
Benefits Think CREATES Act will lower prescription drug costs
By passing this popular bipartisan legislation now, Congress can help make coverage and care more affordable for everyone.
Greg Gierer
America’s Health Insurance Plans
Benefits Think CREATES Act will lower prescription drug costs
By passing this popular bipartisan legislation now, Congress can help make coverage and care more affordable for everyone.
Greg Gierer
America’s Health Insurance Plans
Trump health chief renews call to end key drug-pricing tactic
HHS' Alex Azar told lawmakers that it may be time to eliminate the complex system of rebates that drug companies and pharmacy-benefit managers use to negotiate and set prices.
Benefits Think Employees need help in the hunt for cheaper prescriptions
A pharmacy benefit manager can often find true savings to critical drugs in the same neighborhood.
Heidi Rasmussen
Freshbenies
Benefits Think Employees need help in the hunt for cheaper prescriptions
A pharmacy benefit manager can often find true savings to critical drugs in the same neighborhood.
Heidi Rasmussen
Freshbenies
Cigna takes hopeful step to curb opioid use
The insurer’s 25% reduction in painkiller scripts nearly a year ahead of schedule sets new tone for managing national epidemic, catches large brokerage’s attention.
Benefits Think Why Trump’s drug plan fails employers
By not prioritizing the use of pharmacy benefit management drug rebates, the administration is hurting companies, who shoulder the burden of rising costs by all stakeholders in the supply chain.
Cheryl Larson
Midwest Business Group on Health
Cigna takes hopeful step to curb opioid use
The insurer’s 25% reduction in painkiller scripts nearly a year ahead of schedule sets new tone for managing national epidemic, catches large brokerage’s attention.
Drug prices drive many Americans to black market for medicines
As the Trump administration pledges to bring down America’s high-and-rising drug prices, workers are living with the burden of costly medications.
Benefits Think Why Trump’s drug plan fails employers
By not prioritizing the use of pharmacy benefit management drug rebates, the administration is hurting companies, who shoulder the burden of rising costs by all stakeholders in the supply chain.
Cheryl Larson
Midwest Business Group on Health
Trump drug speech to propose more competition to lower costs
The president will propose a sweeping effort to bring down U.S. drug prices in a plan to make good on a campaign promise.
